BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B

Bombyx Mori

200+ PubMed studies analyzed · Evidence Score: 34

Research Domains

Bombyx Mori has been studied across 17 research domains including 🔥 Metabolic, 🧠 Focus & Attention, 🛡️ Immunity, ⚡ Energy & Fatigue, 🧬 Hormones. The primary research focus is 🔥 Metabolic with 4% of studies addressing this area.

Traditional Use (Ayurveda)

Known as jiangcan / 蠶 in Ayurveda. Karma (actions): Dispels wind-phlegm and scrofulous nodules, Treats childhood fright epilepsy and night crying, Eliminates the three worms, Fades dark spots and blemishes, Improves facial complexion, Stops uterine flooding with red and white discharge, Relieves postpartum residual pain, Treats sores and fades scars, Treats wind stroke with loss of voice, Treats male genital itching and pain, Treats female vaginal discharge, Promotes lactation, Stops uterine bleeding, Treats childhood nutritional sores.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Bombyx Mori, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

eucommia
5789 shared targets
tussilago
5570 shared targets
commiphora
5376 shared targets
prunus
5861 shared targets
Portulaca
5636 shared targets
pinellia
6301 shared targets
apis
5860 shared targets
coix
5718 shared targets
Nelumbo
5981 shared targets
sargassum
5896 shared targets
Loading evidence profile...

This evidence profile for Bombyx Mori is generated deterministically from 200 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.